ASCO 2022 Conference Coverage
Video Player is loading.
10 seconds
Playback speed
ASCO 2022 on Sacituzumab Govitecan vs. Treatment of Physician’s Choice in Previously Treated mTNBC: Final Results From the Phase 3 ASCENT Study
By
ASCO 2022 Conference Coverage
FEATURING
Aditya Bardia
By
ASCO 2022 Conference Coverage
FEATURING
Aditya Bardia
Comments 0
Login to view comments.
Click here to Login
